We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

77 hedge funds and large institutions have $50.3M invested in Applied Genetic Technologies Corporation in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $168K | Put options by funds: $90K

11% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 27

13% less funds holding

Funds holding: 8977 (-12)

33% less capital invested

Capital invested by funds: $75.1M → $50.3M (-$24.8M)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
77
Holders Change
-12
Holders Change %
-13.48%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
24
Reduced
27
Closed
26
Calls
$168K
Puts
$90K
Net Calls
+$78K
Net Calls Change
+$261K
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$394K -$2.73K -487 -0.6%
GIP
27
Granite Investment Partners
California
$375K -$19.9K -3,545 -5%
AG
28
Algert Global
California
$374K
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$361K +$41.6K +7,400 +12%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$302K +$15K +2,666 +5%
American Century Companies
31
American Century Companies
Missouri
$286K
ARTA
32
A.R.T. Advisors
New York
$281K +$192K +34,100 +161%
LP
33
LMR Partners
United Kingdom
$275K +$303K +54,024 New
Bank of America
34
Bank of America
North Carolina
$267K +$10.9K +1,935 +4%
ECM
35
Element Capital Management
New York
$259K +$286K +50,869 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$255K -$44K -7,826 -14%
PP
37
Paloma Partners
Connecticut
$243K +$267K +47,600 New
TC
38
TFS Capital
Pennsylvania
$198K -$119K -21,201 -35%
CS
39
Credit Suisse
Switzerland
$186K +$53K +9,444 +35%
VKH
40
Virtu KCG Holdings
New York
$178K +$196K +34,843 New
Barclays
41
Barclays
United Kingdom
$170K +$112K +19,995 +150%
PP
42
PDT Partners
New York
$169K
UBS Group
43
UBS Group
Switzerland
$161K +$173K +30,871 +3,710%
FDCDDQ
44
Federation des caisses Desjardins du Quebec
Quebec, Canada
$134K
Squarepoint
45
Squarepoint
New York
$120K +$36.5K +6,507 +38%
Northern Trust
46
Northern Trust
Illinois
$108K -$637K -113,498 -84%
Two Sigma Investments
47
Two Sigma Investments
New York
$108K +$119K +21,186 New
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$107K -$33.1K -5,900 -22%
TI
49
Trexquant Investment
Connecticut
$102K +$3.43K +611 +3%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$92K

AGTC Hedge Fund Activity: Q2 2017 in Review

77 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2017, worth a combined $50.3M — down 33% from $75.1M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of AGTC and 15 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 24 added.

The largest buyer was Millennium Management, adding an estimated $1.41M. The largest seller was BlackRock, cutting an estimated $3.06M.

  • 77 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2017, down from 89 in Q1 2017.
  • Funds reported $50.3M of Applied Genetic Technologies Corporation stock for Q2 2017, down 33% quarter-over-quarter.
  • 15 funds opened new Applied Genetic Technologies Corporation positions in Q2 2017 and 26 closed out, a net change of -11 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2017 was Millennium Management, an estimated $1.41M added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2017 was BlackRock, an estimated $3.06M sold.

Based on aggregated 13F filings for Q2 2017.